Market News

NYSE:VLO News

16 stories
marketbeat

Valero Energy Q2 Earnings Call Highlights

Valero Energy NYSE:VLO reported second-quarter 2026 net income attributable to stockholders of $3.7 billion, or $12.62 per share, compared with $714 million, or $2.28 per share, a year earlier, as refining, renewable diesel and ethanol operations all posted stronger results.Adjusted net income was…

MarketBeat en
tradingview

Valero Energy Corp/TX 2026: Revenue $44.48B, EPS $12.62— 10-Q Summary

Valero Energy Corp/TX reported results for 2026 with revenue of $44.48B and diluted earnings per share of $12.62, both up sharply from the prior-year quarter, driven by higher product prices, increased renewable volumes and strength in diesel and gasoline demand.Financial Highlights¹ Reported as “R…

TradingView en
StocksUS

The West Is Losing Refineries Faster Than It Can Replace Them, and One Nasdaq Company Has the Only One in Nevada

Issued on behalf of Sky Quarry Inc.Sky Quarry Inc. (NASDAQ:SKYQ) has moved its Foreland Refinery near Ely, Nevada into its production phase, with roughly 10,000 barrels of inventory on-site and more than 100,000 barrels of storage capacity, while separately working to catalyze new drilling in Railr…

PR Newswire en
indexStocksUS
business_wire

Valero Energy Corporation Declares Regular Cash Dividend on Common Stock

The Board of Directors of Valero Energy Corporation (NYSE: VLO, “Valero”) has declared a regular quarterly cash dividend of $1.20 per share on its common stock. The dividend will be payable on August 31, 2026, to stockholders of record as of the close of business on July 31, 2026.About ValeroValero…

BusinessWire en
StocksUS

The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.

Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ:CNXU) is aiming its investigational CXU™ platform at the largest unclaimed frontier in injectable aesthetics: restoring real body volume at a scale today's fillers were never built to reach, a move built on the company's complet…

PR Newswire en
ETFsStocksUS

The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.

Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ:CNXU) is aiming its investigational CXU™ platform at the largest unclaimed frontier in injectable aesthetics: restoring real body volume at a scale today's fillers were never built to reach, a move built on the company's complet…

PR Newswire en
ETFsStocksUS
tradingview

Valero SVP Sold Shares Worth Over $2M

Eric A Fisher, an officer serving as SVP, sold 7,500 shares of the issuer's common stock at $268.1743 per share on 2026-06-29 for a total of $2,011,307. The sale was a direct disposition of securities. Following the reported transaction, Fisher directly owns 19,742 shares, excluding 1,089.7092 shar…

TradingView en
StocksUS
zacks

Here's How VLO's Strong Balance Sheet Helps Navigate Market Volatility

Valero Energy Corporation VLO operates a diversified portfolio spanning traditional refining, renewable diesel and ethanol operations. Driven by a robust network of 14 refineries and a combined throughput capacity of approximately 3 million barrels per day, Valero generates substantial cash flows f…

Zacks en
StocksUS